Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12

Published: Mar 26, 2021 | Tags: Pfizer and BioNTech, Initiate, COVID-19 Vaccine Trial, Children, Under 12

Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and Antiviral Diseases

Published: Mar 26, 2021 | Tags: Tetra Bio-Pharma, Initiates, Additional Studies, ARDS-003,  Neuroinflammation, Antiviral Diseases

Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

Published: Mar 26, 2021 | Tags: Immunai, Acquire, Dropprint Genomics, Expand, Target, Discovery Capabilities

Astellas and Seagen Report EMA's Acceptance of MAA for Enfortumab Vedotin to Treat Locally Advanced or Metastatic Urothelial Cancer

Published: Mar 26, 2021 | Tags: Astellas and Seagen, Report, EMA, Acceptance, MAA, Enfortumab Vedotin, Treat, Locally, Advanced, Metastatic, Urothelial Cancer

Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue

Published: Mar 26, 2021 | Tags: Takeda, Reports, EMA, Acceptance, TAK-003, Prevention, Dengue

BMS Report Results of Relatlimab + Opdivo (nivolumab) in P-II/III RELATIVITY-047 Study in Patients with Previously Untreated Metastatic or Unresectable Melanoma

Published: Mar 26, 2021 | Tags: BMS, Report, Results, Relatlimab, Opdivo (nivolumab), P-II/III RELATIVITY-047 Study, Patients, Previously, Untreated, Metastatic, Unresectable Melanoma
Pfizer and Myovant Report Results of Relugolix Combination Therapy in P-III LIBERTY Withdrawal Study in Women with Uterine Fibroids

Published: Mar 25, 2021 | Tags: Pfizer and Myovant, Report, Results, Relugolix Combination Therapy, P-III LIBERTY, Withdrawal Study, Women, Uterine Fibroids

ProQR Reports Results of QR-421 in P-I/II Stellar Trial for Usher Syndrome

Published: Mar 25, 2021 | Tags: ProQR, Reports, Results, QR-421, P-I/II Stellar Trial, Usher Syndrome

EirGenix Report Results of EG12014 (biosimilar, trastuzumab) in P-III Trial for HER2-Positive Breast Cancer

Published: Mar 25, 2021 | Tags: EirGenix, Report, Results, EG12014 (biosimilar, trastuzumab), P-III Trial, HER2-Positive Breast Cancer
J&J Visions' Acuvue Theravision with Ketotifen Receives MHLW's Approval for Vision Correction and Allergic Eye Itch

Published: Mar 25, 2021 | Tags: J&J Visions, Acuvue Theravision, Ketotifen, Receives, MHLW, Approval, Vision Correction, Allergic Eye Itch

Chugai's Polivy Receives MHLW's Approval for Relapsed or Refractory Diffuse Large B-cell Lymphoma

Published: Mar 25, 2021 | Tags: Chugai, Polivy, Receives, MHLW, Approval, Relapsed, Refractory Diffuse Large B-cell Lymphoma

AstraZeneca Reports Results of AZD1222 in Primary Analysis of P-III Trial for the Prevention of COVID-19

Published: Mar 25, 2021 | Tags: AstraZeneca, Reports, Results, AZD1222, Primary Analysis, P-III Trial, Prevention, COVID-19

Bayer's Vitrakvi Receives MHLW's Approval for the Treatment of NTRK Fusion-Positive Advanced or Recurrent Solid Tumors

Published: Mar 24, 2021 | Tags: Bayer, Vitrakvi, Receives, MHLW, Approval, Treatment, NTRK Fusion-Positive, Advanced, Recurrent, Solid Tumors

Novo Nordisk Presents Results of Semaglutide in P-IIIa STEP 4 Trial to Treat Obesity at ENDO 2021

Published: Mar 24, 2021 | Tags: Novo Nordisk, Presents, Results, Semaglutide, P-IIIa STEP 4 Trial,  Treat, Obesity

Fresenius Medical Care Collaborates with DaVita to Expand the Use of NxStage Home Hemodialysis Machines

Published: Mar 24, 2021 | Tags: Fresenius Medical Care, Collaborates, DaVita, Expand, Use, NxStage Home Hemodialysis Machines

Incyte's Pemazyre (pemigatinib) Receives MHLW's Approval for Unresectable Biliary Tract Cancer with a FGFR2 Fusion Gene

Published: Mar 24, 2021 | Tags: Incyte, Pemazyre (pemigatinib), Receives, MHLW, Approval,  Unresectable, Biliary Tract Cancer, FGFR2 Fusion Gene

Zealand's Zegalogue (dasiglucagon) Receives the US FDA's Approval for the Treatment of Severe Hypoglycemia

Published: Mar 24, 2021 | Tags: Zealand, Zegalogue (dasiglucagon), Receives, US, FDA, Approval,  Treatment, Severe, Hypoglycemia

Roche Launches New Configurations for Cobas Pro to Increase Testing Efficiency

Published: Mar 24, 2021 | Tags: Roche, Launches, New Configurations, Cobas Pro, Increase, Testing, Efficiency

Regeneron Reports Results of REGEN-COV Antibody Cocktail in P-III Trial to Prevent COVID-19

Published: Mar 23, 2021 | Tags: Regeneron, Reports, Results, REGEN-COV Antibody Cocktail, P-III Trial, Prevent, COVID-19

Novo Nordisk Receives the US FDA's Refusal to File Letter for Semaglutide to Treat T2D

Published: Mar 23, 2021 | Tags: Novo Nordisk, Receives, US, FDA, Refusal, File Letter, Semaglutide, Treat, T2D

Insulet Presents Results of Omnipod 5 Automated Insulin Delivery System for T1D at ENDO 2021

Published: Mar 23, 2021 | Tags: Insulet, Presents, Results, Omnipod 5 Automated Insulin Delivery System, T1D

Roche Pauses Dosing of Tominersen in P-III GENERATION HD1 for Manifest Huntington's Disease

Published: Mar 23, 2021 | Tags: Roche, Pauses, Dosing, Tominersen, P-III GENERATION HD1, Manifest Huntington's Disease

Roche Reports Results of Tecentriq in P-III IMpower010 Study for Patients with Early Lung Cancer

Published: Mar 23, 2021 | Tags: Roche, Reports, Results, Tecentriq, P-III IMpower010 Study, Patients, Early, Lung Cancer

Takeda Collaborates with Evotec on RNA Targeting Drug Development

Published: Mar 23, 2021 | Tags: Takeda, Collaborates, Evotec, RNA Targeting, Drug Development

AstraZeneca's AZD1222 Meets its Primary Endpoint in Preventing COVID-19

Published: Mar 22, 2021 | Tags: AstraZeneca, AZD1222, Meets, Primary Endpoint, Preventing, COVID-19

BioMarin Report Results of Vosoritide in P-III OLE Study for the Treatment of Children with Achondroplasia at ENDO 2021

Published: Mar 22, 2021 | Tags: BioMarin, Report, Results, Vosoritide, P-III OLE Study, Treatment,  Children, Achondroplasia

BridgeBio Presents Results of Encaleret in P-IIb Study for the Treatment of ADH1 at ENDO 2021

Published: Mar 22, 2021 | Tags: BridgeBio, Presents, Results, Encaleret, P-IIb Study, Treatment,  ADH1

Janssen's Ponvory (ponesimod) Receives the US FDA's Approval for the Treatment of Relapsing Multiple Sclerosis

Published: Mar 22, 2021 | Tags: Janssen, Ponvory (ponesimod), Receives, US, FDA, Approval,  Treatment, Relapsing, Multiple Sclerosis

Merck Presents Results of Keytruda (pembrolizumab) + Lenvima (lenvatinib) in P-III KEYNOTE-775/Study 309 trial for the Treatment of Advanced Endometrial Cancer at SGO

Published: Mar 22, 2021 | Tags: Merck, Presents, Results, Keytruda (pembrolizumab), Lenvima (lenvatinib), P-III KEYNOTE-775/Study 309 trial, Treatment, Advanced, Endometrial Cancer

BMS Reports the US FDA's Acceptance of NDA for Mavacamten to Treat Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Published: Mar 22, 2021 | Tags: BMS, Reports, US, FDA, Acceptance, NDA, Mavacamten, Treat, Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Related Post: PharmaShots Weekly Snapshots (Mar 15 - 19, 2021)